Clinical efficacy of SARS-CoV-2 Omicron-neutralizing antibodies in immunoglobulin preparations for the treatment of agammaglobulinemia in patients with primary antibody deficiency.

Auteurs

Karbiener M, Kindle G, Meyts I, Seppänen MRJ, Candotti F, Kamieniak M, Ilk R, Kreil TR, Seidel MG

  • Date de publication

    June 2024

  • Type

    Article

  • Review

    J Med Virol

  • Researcher's name

    Goffard Jean-Christophe

  • Hôpital

    Hôpital Erasme

  • Service

    Médecine Interne

  • PMID

    38884390

  • DOI

    10.1002/jmv.29738